Provectus Biopharmaceuticals, Inc. (PVCT)
OTCMKTS: PVCT · Delayed Price · USD
0.125
0.00 (0.00%)
Jul 2, 2024, 2:30 PM EDT - Market closed
PVCT Market Cap
PVCT has a market cap or net worth of $52.23 million as of July 3, 2024. Its market cap has decreased by -54.42% in one year.
Market Cap
52.23M
Enterprise Value
54.66M
1-Year Change
-54.42%
Ranking
n/a
Category
Stock Price
$0.12
Market Cap Chart
Since March 30, 2006, PVCT's market cap has increased from $38.70M to $52.23M, an increase of 34.96%. That is a compound annual growth rate of 2.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2016 | 11.30M | -85.84% |
| Dec 31, 2015 | 79.80M | -44.66% |
| Dec 31, 2014 | 144.20M | -57.25% |
| Dec 31, 2013 | 337.30M | 429.51% |
| Dec 31, 2012 | 63.70M | -28.27% |
| Dec 30, 2011 | 88.80M | 9.49% |
| Dec 31, 2010 | 81.10M | 37.23% |
| Dec 31, 2009 | 59.10M | 22.11% |
| Dec 31, 2008 | 48.40M | -41.55% |
| Dec 31, 2007 | 82.80M | 75.05% |
| Dec 29, 2006 | 47.30M | 22.22% |
| Mar 30, 2006 | 38.70M | - |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 861.74B |
| Novo Nordisk | 628.28B |
| UnitedHealth Group | 458.57B |
| Johnson & Johnson | 351.45B |
| Merck & Co. | 323.49B |
| AbbVie | 293.06B |
| AstraZeneca | 238.71B |
| Novartis AG | 208.25B |